The newest drugs for the treatment of lupus erythematosus include injectable tetracycline, injectable belimumab. Currently, the newest drugs for the treatment of lupus erythematosus are biologically targeted drugs, including injectable tetracycline and injectable belimumab. They are effective in improving the symptoms of lupus erythematosus, but due to individual differences, it is not guaranteed that all patients can improve their symptoms with these drugs. Therefore, patients should take into account their own situation and ask their doctors for advice. Titazepam for Injection is often used in combination with conventional therapy to treat adult patients with active, autoantibody-positive SLE who still have high disease activity on a conventional treatment basis. However, this drug should be contraindicated in people who are allergic to the components of Titazepam for Injection. Some patients may experience adverse reactions such as malaise, nausea, and upper respiratory infections. Belimumab for Injection is often used in combination with conventional therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus who have high disease activity despite conventional therapy. This drug is contraindicated in people who are allergic to its components. Patients may experience adverse reactions such as pharyngitis, diarrhea, insomnia, nausea. Patients with lupus erythematosus are advised to go to the hospital in time and follow the doctor’s instructions for regular use of medication, rather than self-medication, in order to avoid delays in the condition or the occurrence of adverse reactions.